Control Contact Lens, Then Test Contact Lens for Near-sightedness

Kannarr Eye Care, Pittsburg, KS
Near-sightednessTest Contact Lens (senofilcon A) - Device
Eligibility
18 - 35
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare how two different contact lenses work on comfort, vision and health.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 days of wear

6 days of wear
Lens Handling on Removal

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control Contact Lens, Then Test Contact Lens
1 of 2
Test Contact Lens, Then Control Contact Lens
1 of 2

Experimental Treatment

73 Total Participants · 2 Treatment Groups

Primary Treatment: Control Contact Lens, Then Test Contact Lens · No Placebo Group · N/A

Control Contact Lens, Then Test Contact LensExperimental Group · 2 Interventions: Test Contact Lens (senofilcon A), Control Contact Lens (stenfilcon A) · Intervention Types: Device, Device
Test Contact Lens, Then Control Contact LensExperimental Group · 2 Interventions: Test Contact Lens (senofilcon A), Control Contact Lens (stenfilcon A) · Intervention Types: Device, Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 days of wear

Who is running the clinical trial?

Coopervision, Inc.Lead Sponsor
145 Previous Clinical Trials
12,874 Total Patients Enrolled
COREUNKNOWN
5 Previous Clinical Trials
1,951 Total Patients Enrolled
Shane KannarrPrincipal InvestigatorShane Kannarr Eye Care
2 Previous Clinical Trials
137 Total Patients Enrolled
Stephen M MontaquilaPrincipal InvestigatorWest Bay Eye Associate
Mike CymborPrincipal InvestigatorNittany Eye Associate
Lyndon Jones, phD,FCOptomStudy DirectorCentre for Ocular Research and Education
Gina Wesley, OD,MS,FAAOPrincipal InvestigatorComplete Eye Care of Medina/Complete Vision Solutions

Eligibility Criteria

Age 18 - 35 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What criteria must be met in order to participate in this investigation?

"To qualify for this trial, the applicant must be farsighted and between 18-35 years old. The team is hoping to enrol 73 individuals in total." - Anonymous Online Contributor

Unverified Answer

What is the prevalence of this experiment across various locations?

"Currently, participants can join this trial at Complete Eye Care of Medina/Complete Vision Solutions in Medina, Nittany Eye Associate in State College, and West Bay Associate in Warwick. Additionally, there are four other available sites to enroll from." - Anonymous Online Contributor

Unverified Answer

How many participants are currently contributing to this research project?

"Coopervision, Inc. is mandated to gather 73 patients that are eligible for the trial and will do so at two locations - Complete Eye Care of Medina/Complete Vision Solutions in Medina, Minnesota and Nittany Eye Associate in State College, Pennsylvania." - Anonymous Online Contributor

Unverified Answer

Are any new participants being sought for this experimental program?

"Indeed, the data accessible on clinicaltrials.gov states that this trial is still seeking participants. It was initially posted on February 28th 2023 and underwent its most recent revision on March 28th 2023 with a goal of recruiting 73 patients from 4 different sites." - Anonymous Online Contributor

Unverified Answer

Is the elderly population being included in this research endeavor?

"This experiment has a strict eligibility range of 18 to 35 years old. There are 72 studies available for minors and 18 dedicated research programs for seniors aged 65 or above." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.